Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge
Cambridge University Press
2018
|
| Links: | https://doi.org/10.1017/9781316459263 |
| Summary: | In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations. |
| Physical Description: | 1 Online-Ressource (xiv, 542 Seiten) |
| ISBN: | 9781316459263 |
Staff View
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-20-CTM-CR9781316459263 | ||
| 003 | UkCbUP | ||
| 005 | 20180123164450.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 150508s2018||||enk o ||1 0|eng|d | ||
| 020 | |a 9781316459263 | ||
| 100 | 1 | |a Rea, Philip A. |d 1957- | |
| 245 | 1 | 0 | |a Managing discovery in the life sciences |b harnessing creativity to drive biomedical innovation |c Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2018 | |
| 300 | |a 1 Online-Ressource (xiv, 542 Seiten) | ||
| 336 | |b txt | ||
| 337 | |b c | ||
| 338 | |b cr | ||
| 520 | |a In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations. | ||
| 700 | 1 | |a Burns, Lawton R. | |
| 700 | 1 | |a Pauly, Mark V. |d 1941- | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781107130906 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781107577305 |
| 966 | 4 | 0 | |l DE-91 |p ZDB-20-CTM |q TUM_PDA_CTM |u https://doi.org/10.1017/9781316459263 |3 Volltext |
| 912 | |a ZDB-20-CTM | ||
| 912 | |a ZDB-20-CTM | ||
| 049 | |a DE-91 | ||
Record in the Search Index
| DE-BY-TUM_katkey | ZDB-20-CTM-CR9781316459263 |
|---|---|
| _version_ | 1832177784837898240 |
| adam_text | |
| any_adam_object | |
| author | Rea, Philip A. 1957- |
| author2 | Burns, Lawton R. Pauly, Mark V. 1941- |
| author2_role | |
| author2_variant | l r b lr lrb m v p mv mvp |
| author_facet | Rea, Philip A. 1957- Burns, Lawton R. Pauly, Mark V. 1941- |
| author_role | |
| author_sort | Rea, Philip A. 1957- |
| author_variant | p a r pa par |
| building | Verbundindex |
| bvnumber | localTUM |
| collection | ZDB-20-CTM |
| format | eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01983nam a2200277 i 4500</leader><controlfield tag="001">ZDB-20-CTM-CR9781316459263</controlfield><controlfield tag="003">UkCbUP</controlfield><controlfield tag="005">20180123164450.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr||||||||||||</controlfield><controlfield tag="008">150508s2018||||enk o ||1 0|eng|d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781316459263</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rea, Philip A.</subfield><subfield code="d">1957-</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Managing discovery in the life sciences</subfield><subfield code="b">harnessing creativity to drive biomedical innovation</subfield><subfield code="c">Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiv, 542 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burns, Lawton R.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pauly, Mark V.</subfield><subfield code="d">1941-</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781107130906</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781107577305</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-91</subfield><subfield code="p">ZDB-20-CTM</subfield><subfield code="q">TUM_PDA_CTM</subfield><subfield code="u">https://doi.org/10.1017/9781316459263</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield></record></collection> |
| id | ZDB-20-CTM-CR9781316459263 |
| illustrated | Not Illustrated |
| indexdate | 2025-05-15T09:21:36Z |
| institution | BVB |
| isbn | 9781316459263 |
| language | English |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (xiv, 542 Seiten) |
| psigel | ZDB-20-CTM TUM_PDA_CTM ZDB-20-CTM |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Rea, Philip A. 1957- Managing discovery in the life sciences harnessing creativity to drive biomedical innovation Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania Cambridge Cambridge University Press 2018 1 Online-Ressource (xiv, 542 Seiten) txt c cr In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations. Burns, Lawton R. Pauly, Mark V. 1941- Erscheint auch als Druck-Ausgabe 9781107130906 Erscheint auch als Druck-Ausgabe 9781107577305 |
| spellingShingle | Rea, Philip A. 1957- Managing discovery in the life sciences harnessing creativity to drive biomedical innovation |
| title | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation |
| title_auth | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation |
| title_exact_search | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation |
| title_full | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania |
| title_fullStr | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania |
| title_full_unstemmed | Managing discovery in the life sciences harnessing creativity to drive biomedical innovation Philip A. Rea, University of Pennsylvania, Mark V. Pauly, University of Pennsylvania, Lawton R. Burns, University of Pennsylvania |
| title_short | Managing discovery in the life sciences |
| title_sort | managing discovery in the life sciences harnessing creativity to drive biomedical innovation |
| title_sub | harnessing creativity to drive biomedical innovation |
| work_keys_str_mv | AT reaphilipa managingdiscoveryinthelifesciencesharnessingcreativitytodrivebiomedicalinnovation AT burnslawtonr managingdiscoveryinthelifesciencesharnessingcreativitytodrivebiomedicalinnovation AT paulymarkv managingdiscoveryinthelifesciencesharnessingcreativitytodrivebiomedicalinnovation |